Loading…
OnKure Therapeutics, Inc. is projected to rise to $4.25 by 2027, a +4% move from its current price of $4.10. OKUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.91 | $4.10 | $4.30 | -0.05% |
| May 30 | $3.83 | $4.10 | $4.38 | -0.11% |
| May 31 | $3.77 | $4.09 | $4.44 | -0.16% |
| Jun 1 | $3.72 | $4.09 | $4.50 | -0.22% |
| Jun 2 | $3.68 | $4.09 | $4.55 | -0.27% |
| Jun 3 | $3.64 | $4.09 | $4.59 | -0.33% |
| Jun 4 | $3.60 | $4.08 | $4.63 | -0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.60 | $4.08 | $4.63 | -0.38% |
| Week 2 | $3.41 | $4.07 | $4.86 | -0.76% |
| Week 3 | $3.26 | $4.05 | $5.04 | -1.14% |
| Week 4 | $3.14 | $4.04 | $5.19 | -1.51% |
| Week 5 | $3.04 | $4.02 | $5.33 | -1.89% |
| Week 6 | $2.95 | $4.01 | $5.45 | -2.26% |
| Week 7 | $2.86 | $3.99 | $5.56 | -2.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate is OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation, in Phase 1 clinical trial for solid tumors, including breast cancer.
The company was founded in 2011 and is headquartered in Boulder, Colorado. It operates in the Healthcare sector.
OKUR is the stock ticker for OnKure Therapeutics, Inc., a biotechnology company with a market capitalization of $170.06M and a market rank of 3947. The current price is $4.21 per share.
The forecast suggests a path of gradual upside over the horizon, with the 2026 average price at $4.21 and rising in subsequent years (for example, 2027 average $4.26; 2028 average $6.58; 2029 average $7.75; 2030 average $8.02). By 2050, the average forecast reaches $29.20 and the max forecast reaches $67.16, implying meaningful long-term upside and a cumulative trajectory from the current level.
A major floor 52.2% below — a decisive break under it would weaken the trend.
The nearest floor, 24.9% below — buyers have tended to step in here.
The nearest ceiling, 28.5% above — a clean break opens room to run.
A major ceiling 54.6% above — clearing it would confirm fresh momentum.
Key OKUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OKUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.01 | Buy | $3.98 | Buy |
| MA 10 | $3.63 | Buy | $3.87 | Buy |
| MA 20 | $3.97 | Buy | $3.95 | Buy |
| MA 50 | $4.25 | Sell | $3.98 | Buy |
| MA 100 | $3.56 | Buy | $3.73 | Buy |
| MA 200 | $3.20 | Buy | $3.92 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.25 | Neutral |
| Stoch RSI (14) | 91.56 | Sell |
| CCI (20) | 17.37 | Neutral |
| Williams %R (14) | -9.73 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 4.86 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 90.27 | Sell |
| TRIX (15) | -0.69 | Sell |
| Awesome (5,34) | -0.28 | Sell |
| Ultimate (7,14,28) | 69.71 | Neutral |
| Momentum (10) | 0.71 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 4.37 | Sell |
| ADX (14) | 23.75 | Buy |
| ATR (14) | 0.17 | Info |
The near-term technical picture is bullish overall. RSI(14) is 50, and the price sits close to the 50-day simple moving average of $4.24 (the current price is $4.21), while the 200-day moving average stands at $3.18.
Support is noted at $3.08 and resistance at $5.27, with a 30-day price range of $3.02 to $5.87. The stock’s annualized volatility is 100%, illustrating elevated short-term dispersion around price movements.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.32 | $4.10 | $5.86 | 0% | Neutral | |
| $3.13 | $4.25 | $6.22 | +4% | Neutral | |
| $4.42 | $6.32 | $9.80 | +54% | Bullish | |
| $5.06 | $7.56 | $12.23 | +84% | Bullish | |
| $5.06 | $7.87 | $13.22 | +92% | Bullish | |
| $4.87 | $7.86 | $13.61 | +92% | Bullish | |
| $4.45 | $7.43 | $13.24 | +81% | Bullish | |
| $4.83 | $8.36 | $15.26 | +104% | Bullish | |
| $5.73 | $10.23 | $19.12 | +150% | Bullish | |
| $6.69 | $12.35 | $23.57 | +201% | Bullish | |
| $6.81 | $14.62 | $30.46 | +257% | Bullish | |
| $13.28 | $29.52 | $67.90 | +620% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.32 | $4.10 | $4.81 | +0.00% |
| June 2026 | $3.18 | $3.79 | $4.68 | -7.50% |
| July 2026 | $3.22 | $3.90 | $4.92 | +2.87% |
| August 2026 | $3.38 | $4.14 | $5.32 | +6.21% |
| September 2026 | $3.28 | $4.06 | $5.29 | -1.96% |
| October 2026 | $3.23 | $4.03 | $5.31 | -0.79% |
| November 2026 | $3.41 | $4.30 | $5.73 | +6.61% |
| December 2026 | $3.43 | $4.35 | $5.86 | +1.25% |
Click any year to see its month-by-month OKUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OKUR is projected to trade between $2.32 and $5.86, averaging $4.10 — a potential gain of 0% from today's $4.10. Price action looks broadly range-bound.
OnKure Therapeutics, Inc.'s 2027 outlook centres on $4.25, within a $3.13 to $6.22 range. That is up +4% on the projected 2026 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, OKUR could reach as high as $9.80, with a base case around $6.32 and support toward $4.42 — roughly +54% from $4.10. Momentum favours further upside here.
Expect OKUR to range from $5.06 to $12.23 through 2029. The $7.56 average target implies a +84% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OKUR price prediction for 2030 points to an average of $7.87 (low $5.06, high $13.22) — a potential gain of +92% on today's $4.10. Momentum favours further upside here.
In 2031, OKUR is projected to trade between $4.87 and $13.61, averaging $7.86 — a potential gain of +92% from today's $4.10. That is 0% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
OnKure Therapeutics, Inc.'s 2032 outlook centres on $7.43, within a $4.45 to $13.24 range. That is -5% versus the projected 2031 average. That marks a +81% change versus current levels. Momentum favours further upside here.
By 2033, OKUR could reach as high as $15.26, with a base case around $8.36 and support toward $4.83 — roughly +104% from $4.10. Buyers look set to stay in control over this stretch.
Expect OKUR to range from $5.73 to $19.12 through 2034. The $10.23 average target implies a +150% move from current prices. That is up +22% on the projected 2033 average. Momentum favours further upside here.
The OKUR price prediction for 2035 points to an average of $12.35 (low $6.69, high $23.57) — a potential gain of +201% on today's $4.10. Buyers look set to stay in control over this stretch.
In 2040, OKUR is projected to trade between $6.81 and $30.46, averaging $14.62 — a potential gain of +257% from today's $4.10. That is up +18% on the projected 2035 average. Momentum favours further upside here.
OnKure Therapeutics, Inc.'s 2050 outlook centres on $29.52, within a $13.28 to $67.90 range. That is up +102% on the projected 2040 average. That marks a +620% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OKUR today (≈ 243.902439 OKUR) could be worth
$7,200.01
+$6,200.01 (+620%) by 2050 · US Dollar
Based on the average projected OKUR price of $29.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OKURwould be worth at today's price.
$1,000 invested in OKUR on May 27, 2025 (≈ 442.477878 OKUR) would be worth
$1,814.16
+$814.16 (+81.4%) today · 1.81× · US Dollar
Based on a OKUR entry price of $2.26 vs. today's $4.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.56 | $1,151.69 | +15.2% |
| 1 month ago | $4.99 | $821.64 | -17.8% |
| 3 months ago | $2.66 | $1,541.35 | +54.1% |
| 6 months ago | $3.01 | $1,362.13 | +36.2% |
| 1 year ago | $2.26 | $1,814.16 | +81.4% |
| All time (5.0y) ago | $107.8 | $38.03 | -96.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OKUR forecast.
Our base-case forecast reaches $8.20 around 2033.
Implied market cap at $8.20: $331.24M
The multi-year forecast presents a bullish trajectory across the horizon. The 2026 forecast shows an average price of $4.21 with neutral sentiment and 0% ROI, transitioning to a bullish outlook in later years.
From 2028 onward, the forecast shows higher averages and growing upside: 2028 avg $6.58 (56.4% ROI), 2029 avg $7.75 (84.1%), 2030 avg $8.02 (90.5%), 2031 avg $8.07 (91.7%), 2032 avg $7.42 (76.4%), 2033 avg $8.41 (99.7%), 2034 avg $10.45 (148.2%), 2035 avg $12.43 (195.3%), 2040 avg $14.80 (251.5%), and 2050 avg $29.20 (593.6%). The 2050 max is forecast at $67.16 with bullish sentiment.
These are estimates, not guarantees, and actual results depend on clinical progress, regulatory outcomes, and market factors.
Tap a question to reveal the answer.
20230avg $8.02, min $5.05, max $13.72; ROI 90.5%; sentiment BULLISH.
Forecasts show neutral sentiment in 2026–2027, then bullish upside with substantial potential by 2050 (avg $29.20, max $67.16; ROI 593.6%). This is not a guarantee and depends on future events.
Yes—the forecasted 2050 max is $67.16.
Current price is $4.21 and market capitalization is $170.06M.
Sentiment is BULLISH; RSI14 is 50. SMA50 is $4.24, SMA200 is $3.18; support is $3.08 and resistance is $5.27. The 30-day range is $3.02 to $5.87, with annualized volatility of 100%.
OnKure Therapeutics, Inc. Community Discussion
0Share your OnKure Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.